Showing results (241-250 of 357) with videos related to

Sort By:
Pageof 36
Gastroenterologia Y Hepatologia|February 18, 2014
[Safe prescription recommendations for non steroidal anti-inflammatory drugs: Consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG)]Angel Lanas, Pere Benito, Joaquín Alonso, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 4, 2015
Pentraxin 3 and Platelet Activation in Obese Patients After Gastric BandingFrancesca Santilli, Maria Teresa Guagnano, Paolo Innocenti, et al.
Gastroenterology|November 8, 2006
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomasJohn A Baron, Robert S Sandler, Robert S Bresalier, et al.
Nature Reviews. Disease Primers|April 20, 2018
Non-variceal upper gastrointestinal bleedingAngel Lanas, Jean-Marc Dumonceau, Richard H Hunt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 3, 2009
Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessmentEdgardo Smecuol, Maria Ines Pinto Sanchez, Alejandro Suarez, et al.
Scientific Reports|May 7, 2021
Endogenous PCSK9 may influence circulating CD45neg/CD34bright and CD45neg/CD34bright/CD146neg cells in patients with type 2 diabetes mellitusRomina Tripaldi, Paola Lanuti, Paola Giustina Simeone, et al.
Life (Basel, Switzerland)|April 27, 2024
Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative ReviewAndrea Boccatonda, Lorenza Del Cane, Lara Marola, et al.
Blood Advances|November 26, 2025
Circulating MRP8/14 drives faster platelet COX-1 recovery via MRP4 impairing the duration of aspirin responseRossella Liani, Paola Giustina Simeone, Margherita Alfonsetti, et al.
Clinical Therapeutics|March 6, 2012
The APC and PreSAP trials: a post hoc noninferiority analysis using a comprehensive new measure for gastrointestinal tract injury in 2 randomized, double-blind studies comparing celecoxib and placeboNadir Arber, David Lieberman, Timothy C Wang, et al.
The American Journal of Gastroenterology|July 19, 2008
Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirinNeville Yeomans, Angel Lanas, Joachim Labenz, et al.
Pageof 36